ClinicalTrials.govpublic full text
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
non-small cell lung cancer (nsclc), nsclc, metastatic, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 810833
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.